This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

EV1195

A holistic approach to recovery and well-being in patients with psychotic disorders: a follow-up study

INTEGRATIVE APPROACH TO RECOVERY AND WELLBEING PATIENTS WITH PSYCHOTIC DISORDERS: A FOLLOW-UP STUDY

At the end of a three-month structured holistic treatment program, significant improvements were observed in measures of psychopathology, functioning, remission, and quality of life, with no change only in perceived stigma.

The aim of the study was to examine the effectiveness of a three-month structured treatment program incorporating evidence-based psychotherapeutic and sociotherapeutic interventions in addition to psychopharmacotherapy, and to assess changes in psychopathology, functioning, and perceived quality of life. Patients who had recently experienced an acute psychotic episode were enrolled in the program, excluding those with psychotic symptoms induced by psychoactive substance use. The program included weekly group interventions (psychoeducation, relaxation, metacognitive training, and exercise), weekly individual psychodynamically oriented psychotherapy, and monthly family, nutrition, and peer support sessions. Assessments before and after treatment used the PANSS, GAF, PDS for perceived stigma, FROGS for remission, and WHOQOL for quality of life; differences were examined using a paired-samples t-test, and effect sizes (Cohen's dz) were calculated. Seventeen patients completed the baseline and follow-up assessments; the majority of the sample were women (N = 16; 94.1%), 13 (76.5%) were high school graduates, the mean age was 46.76 ± 9.85 years, and the mean number of hospitalizations was 5.12 ± 3.14. Significant improvements were found in PANSS subscale and total scores: PANSS P decreased from 12.59 ± 3.74 to 10.18 ± 2.51 (t(16) = 3.69; p = 0.002; dz = 0.90), PANSS N from 19.24 ± 4.99 to 14.29 ± 4.96 (t = 5.67; p < 0.001; dz = 1.37), PANSS G from 37.35 ± 3.35 to 27.65 ± 5.84 (t = 6.59; p < 0.001; dz = 1.60), and PANSS total from 69.18 ± 10.84 to 52.12 ± 11.77 (t = 7.03; p < 0.001; dz = 1.71). Significant improvements were also observed in measures of functioning, quality of life, and remission: GAF increased from 53.41 ± 8.76 to 63.94 ± 10.50 (t = -6.86; p < 0.001; dz = 1.66), WHOQOL from 77.88 ± 12.17 to 88.24 ± 11.57 (t = -4.86; p < 0.001; dz = 1.18), and FROGS total from 68.19 ± 18.41 to 87.88 ± 29.62 (t = -3.65; p = 0.002; dz = 0.91). In contrast, the PDS score changed from 30.12 ± 5.23 to 30.71 ± 4.31, with no significant difference (t = -1.07; p = 0.300; dz = 0.26). The authors state that functional recovery in psychotic disorders requires interventions beyond psychopharmacotherapy, that this pilot study found significant effects in all domains except perceived stigma, and that reducing stigma is a priority for future interventions.

All WCP 2026 summaries